U.S.: FDA decides against blockbuster breast-cancer drug Avastin
- what A blockbuster drug for breast cancer, Avastin, lost its FDA approval to be used for that particular purpose. (It will remain on the market as a cancer drug for other uses — including colon cancer — and Medicare will still cover it for breast cancer usage.)
- why Multiple studies have shown that the drug only helps shrink tumors a little bit, and the side effects don’t make up for that benefit, the FDA decided. The decision means that many insurance providers will likely no longer cover the drug, which is very expensive. source